Cordlife’s operation licences renewed for one year
It has also requested for lifting of trading halt
Add BT as a preferred source
EMBATTLED cord-blood bank Cordlife’s cord blood banking service and human tissue banking service licences have been renewed by the Ministry of Health (MOH) for one year, with effect from Tuesday (Jan 14).
“The company is committed to meeting all applicable regulatory requirements and compliance measures, before considering the full resumption of operations in Singapore,” said Cordlife in a bourse filing after market close on Tuesday.
Cordlife added that at the current stage, it is unable to assess the impact on its fiscal performance for the financial year ending Dec 31, 2025.
Previously, MOH allowed the company to resume its cord blood banking service operations “in a controlled manner”, restricting its operations to not more than 30 units per month of new cord blood from infant donors, until Monday.
In a separate filing, Cordlife requested for a lifting of its trading halt. It called for a trading halt before market opened on Tuesday.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Koh Brothers Eco Engineering faces up to S$57.6 million in potential liabilities from legal disputes
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Car-rental firm Charlotte Vehicle allegedly owes about S$140,000 to 34 customers
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
